Company Guardion Health Sciences Inc Nasdaq
Equities
US40145Q2030
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Nutritional Supplements
97.2
%
| - | - | 12 | 97.2 % | - |
Ocular
2.8
%
| - | - | 0 | 2.8 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
100.0
%
| 11 | 99.8 % | 12 | 100.0 % | +11.04% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jan Hall
CEO | Chief Executive Officer | - | 19/23/19 |
Chairman | 72 | 30/15/30 | |
Katie Cox
AUD | Comptroller/Controller/Auditor | - | 25/23/25 |
Susan Klein
PRN | Corporate Officer/Principal | - | - |
Craig Sheehan
PRN | Corporate Officer/Principal | 53 | 03/21/03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 72 | 30/15/30 | |
Mark Goldstone
BRD | Director/Board Member | 60 | 01/15/01 |
Donald Gagliano
BRD | Director/Board Member | 71 | 09/19/09 |
Michaela Griggs
BRD | Director/Board Member | - | 09/21/09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,284,156 | 1,029,559 ( 80.17 %) | 0 | 80.17 % |
Company contact information
Guardion Health Sciences, Inc.
2925 Richmond Avenue Suite 1200
77098, Houston
+800 873 5141
http://www.guardionhealth.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+31.37% | 588B | |
-2.77% | 364B | |
+20.38% | 326B | |
+5.53% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.23% | 167B | |
+0.14% | 161B |